药物信息为ORAVIG (miconazole) buccal tablets (Par Pharmaceuticals Companies, Inc.): 11 DESCRIPTION
- 1 INDICATIONS AND USAGE
- 3 DOSAGE FORMS AND STRENGTHS
- 4 CONTRAINDICATIONS
- 6 ADVERSE REACTIONS
- 10 OVERDOSAGE
- 11 DESCRIPTION
- 14 CLINICAL STUDIES
- 16 HOW SUPPLIED/STORAGE AND HANDLING
- 17 PATIENT COUNSELING INFORMATION
- FDA-Approved Patient Labeling
- Principal Display Panel - Bottle Label
- Principal Display Panel - Carton Label
- Principal Display Panel - Bottle Label - 2 Tablet Professional SAMPLE
- Principal Display Panel - Carton Label - 2 Tablet Professional SAMPLE
- 外部链接相关的ORAVIG (miconazole) buccal tablets (Par Pharmaceuticals Companies, Inc.)
ORAVIG (miconazole) buccal tablets are applied topically to the gum once daily and release miconazole as the buccal tablet gradually dissolves [see Clinical Pharmacology (12.3)].
Miconazole is an imidazole antifungal agent and is described chemically as 1-[(2RS)-2-[(2,4-dichlorobenzyl) oxy]-2-(2,4-dichlorophenyl) ethyl]-1H-imidazole with an empirical formula of C18H14Cl4N2O and a molecular weight of 416.13. The structural formula is shown in Figure 1.

Miconazole drug substance is a white to almost white powder.
ORAVIG contains 50 mg of miconazole base, USP and the following inactive ingredients: hypromellose, USP; milk protein concentrate; corn starch, NF; lactose monohydrate, NF; sodium lauryl sulfate, NF; magnesium stearate, NF; and talc, USP.
- Drug Information Provided by National Library of Medicine (NLM).
